Thanks, Mr. Chair.
I'd like to thank the two witnesses, Dr. Young and Dr. Blais, for being here.
Dr. Young, you submitted a brief in February 2022 as part of our Successes, Challenges and Opportunities for Science in Canada study.
Today, you talked about the mind, the human brain, and what that all could mean. You gave examples related to autism, Parkinson's disease, Asperger's syndrome and other mental illnesses. You also talked about a “dementia zero” goal by 2050, and aging-related illnesses.
Are there targets for each degenerative disease? Can you briefly explain what leads you to be able to predict what's to come in25 years for dementia, when you can't do that for autism or Asperger's syndrome?